95% said that Gaia Herbs supplements have had a positive impact on their health & wellness.* 16,000+ Five-star reviews WELLNESS GROWS HERE *In a survey conducted of 396 Gaia customers
The article flags rapid weight regain, unmanageable hunger, or metabolic instability as signals that continued medical support may be warranted
What Is GLP-1 shots
However, most obesity specialists agree that obesity is a multifaceted disease that can involve genetic predisposition and dysfunction of certain hormones, including ghrelin (a hunger hormone) and leptin (a satiety hormone)
For patients who did experience side effects, clinicians controlled symptoms by reducing the dose temporarily, providing basic home advice such as eating small meals or bland foods, and monitoring for evidence of dehydration
Food and Drug Administration: (May 2022) Approved as adjunct to diet and exercise for glycemic control in adults with type 2 diabetes mellitus (November 2023) Approved for chronic weight management in adults with obesity or overweight with at least one weight-related comorbidity (December 2024) Expanded indication for moderate-to-severe obstructive sleep apnea in adults with obesity Classified as first-in-class dual GIP/GLP-1 receptor agonist Not approved for type 1 diabetes mellitus or as monotherapy in patients with history of pancreatitis International Regulatory Approvals GLP2 has received regulatory approval in multiple jurisdictions: European Union (September 2022) Type 2 diabetes treatment United Kingdom (November 2023) Expanded to include weight management Canada (November 2022) Type 2 diabetes indication Australia (December 2022) Type 2 diabetes treatment Additional regulatory reviews ongoing in other countries Warnings and Contraindications Important safety considerations include: Boxed Warning for thyroid C-cell tumor risk (based on rodent studies
.png)
